Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer

Figure 8

A boxplot presented compositional differences of 22 immunocytes between the low-risk group (S1) and the high-risk group (S2).